tiprankstipranks
Bioatla, Inc. (BCAB)
NASDAQ:BCAB
US Market
Want to see BCAB full AI Analyst Report?

BioAtla (BCAB) Stock Forecast & Price Target

790 Followers
See the Price Targets and Ratings of:

BCAB Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
BioAtla
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BCAB Stock 12 Month Forecast

There Are No Analyst Ratings for BCAB In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

BCAB Financial Forecast

BCAB Earnings Forecast

The previous quarter’s earnings for BCAB were -$8.00.
The previous quarter’s earnings for BCAB were -$8.00.

BCAB Sales Forecast

The previous quarter’s earnings for BCAB were $2.00M.
The previous quarter’s earnings for BCAB were $2.00M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Rodman & Renshaw Analyst forecast on BCAB
Rodman & Renshaw
Rodman & Renshaw
$4
Buy
2005.26%
Upside
Initiated
01/13/26
BioAtla initiated with a Buy at Rodman & RenshawBioAtla initiated with a Buy at Rodman & Renshaw
BTIG
$10
Buy
5163.16%
Upside
Reiterated
11/14/25
BioAtla's Strategic Advancements and Promising Clinical Data Drive Buy Rating
Citizens JMP Analyst forecast on BCAB
Citizens JMP
Citizens JMP
Hold
Reiterated
09/09/25
Citizens JMP Sticks to Its Hold Rating for BioAtla (BCAB)
H.C. Wainwright Analyst forecast on BCAB
H.C. Wainwright
H.C. Wainwright
Hold
Reiterated
08/11/25
H.C. Wainwright Reaffirms Their Hold Rating on BioAtla (BCAB)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Rodman & Renshaw Analyst forecast on BCAB
Rodman & Renshaw
Rodman & Renshaw
$4
Buy
2005.26%
Upside
Initiated
01/13/26
BioAtla initiated with a Buy at Rodman & RenshawBioAtla initiated with a Buy at Rodman & Renshaw
BTIG
$10
Buy
5163.16%
Upside
Reiterated
11/14/25
BioAtla's Strategic Advancements and Promising Clinical Data Drive Buy Rating
Citizens JMP Analyst forecast on BCAB
Citizens JMP
Citizens JMP
Hold
Reiterated
09/09/25
Citizens JMP Sticks to Its Hold Rating for BioAtla (BCAB)
H.C. Wainwright Analyst forecast on BCAB
H.C. Wainwright
H.C. Wainwright
Hold
Reiterated
08/11/25
H.C. Wainwright Reaffirms Their Hold Rating on BioAtla (BCAB)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering BioAtla

3 Months
xxx
Success Rate
3/6 ratings generated profit
50%
Average Return
-8.18%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -8.18% per trade.
1 Year
Success Rate
0/6 ratings generated profit
0%
Average Return
-73.65%
Copying Justin Zelin's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -73.65% per trade.
2 Years
xxx
Success Rate
0/6 ratings generated profit
0%
Average Return
-82.40%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -82.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BCAB Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
1
2
1
1
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
2
1
1
0
In the current month, BCAB has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BCAB average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

BCAB Stock Forecast FAQ

What is BCAB’s average 12-month price target, according to analysts?
Currently, no data Available
What is BCAB’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for BCAB, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is BCAB a Buy, Sell or Hold?
      Currently, no data Available
      What is Bioatla, Inc.’s price target?
      Currently, no data Available
      What do analysts say about Bioatla, Inc.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of BCAB?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.